Clinical trial
Efficacy of Nicotinamide for the Treatment of Alzheimer's Disease
NCT00580931 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Nicotinamide for the Treatment of Alzheimer's Disease
- Lead sponsor
- University of California, Irvine
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- July 31, 2014
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease